Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shigeki Saito is active.

Publication


Featured researches published by Shigeki Saito.


Biochemical and Biophysical Research Communications | 2011

Pharmacological inhibition of HDAC6 attenuates endothelial barrier dysfunction induced by thrombin

Shigeki Saito; Joseph A. Lasky; Weichao Guo; Hong Nguyen; Antonello Mai; Svitlana Danchuk; Deborah E. Sullivan; Bin Shan

BACKGROUND Endothelial barrier dysfunction (EBD) involves microtubule disassembly and enhanced cell contractility. Histone deacetylase 6 (HDAC6) deacetylates α-tubulin, and thereby destabilizes microtubules. This study investigates a role for HDAC6 in EBD. METHODS EBD was induced with thrombin±HDAC6 inhibitors (tubacin and MC1575), and assessed by transendothelial electrical resistance (TEER). Markers for microtubule disassembly (α-tubulin and acetylated α-tubulin) and contraction (phosphorylated myosin light chain 2, P-MLC2) were measured using immunoblots and immunofluorescence. RESULTS AND CONCLUSION Thrombin induced a ∼50% decrease in TEER that was abrogated by the HDAC6 inhibitors. Moreover, inhibition of HDAC6 diminished edema in the lung injured by lipopolysaccharide. Lastly, inhibition of HDAC6 attenuated thrombin-induced microtubule disassembly and P-MLC2. Our results suggest that HDAC6 can be targeted to limit EBD.


Respiratory investigation | 2018

Ethnic differences in idiopathic pulmonary fibrosis: The Japanese perspective

Shigeki Saito; Joseph A. Lasky; Koichi Hagiwara; Yasuhiro Kondoh

Epidemiologic data suggest that there are ethnic differences between Japanese and other populations with regard to the important clinical aspects of interstitial lung disease (ILD), such as the cause of death and prognostic factors in patients with idiopathic pulmonary fibrosis (IPF). Acute exacerbation (AE) of IPF may be more common in Japan than in the rest of the world, although this suggestion remains controversial. Moreover, AE of ILD induced by gefitinib may also be more common in Japan, indicating that Japanese patients have a genetic vulnerability or susceptibility to AE. Recent large-scale studies are starting to reveal ethnic differences in the genetics of ILD, including the prevalence of the genetic polymorphisms associated with the clinical course of ILD. We anticipate that ongoing and upcoming research regarding ethnic differences will continue to provide valuable insights into the pathogenesis and management of ILD.


Genomics | 2018

Proportions of resting memory T cells and monocytes in blood have prognostic significance in idiopathic pulmonary fibrosis

Yao-Zhong Liu; Shigeki Saito; Gilbert F. Morris; Charles A. Miller; Jian Li; John J. Lefante

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by progressive decline of lung function. Here, we tested the importance of differential proportions of blood immune cells to IPF clinical outcomes. We used Cibersort to deconvolute immune cell components based on PBMCs or whole blood IPF genomics datasets. We found that a higher proportion of resting memory (RM) T cells was associated with a better survival and a higher DLco (diffusing capacity for carbon monoxide) in IPF patients. The association was also found in opposite direction for monocytes. Additionally, in IPF patients as compared to healthy controls, proportions of monocytes were observed to be higher, yet RM T cells were observed to be lower. Taken together, our result suggests a beneficial effect of RM T cells and a detrimental effect of monocytes for IPF. Future genomics studies of IPF should be more focused on these two types of cells.


American Journal of Physiology-lung Cellular and Molecular Physiology | 2018

HDAC8 inhibition ameliorates pulmonary fibrosis.

Shigeki Saito; Yan Zhuang; Takayoshi Suzuki; Yosuke Ota; Marjorie E. Bateman; Ala L Alkhatib; Gilbert F. Morris; Joseph A. Lasky

Idiopathic pulmonary fibrosis (IPF) is a fibroproliferative lung disease, and fibroblast-myofibroblast differentiation (FMD) is thought to be a key event in the pathogenesis of IPF. Histone deacetylase-8 (HDAC8) has been shown to associate with α-smooth muscle actin (α-SMA; a marker of FMD) and regulates cell contractility in vascular smooth muscle cells. However, the role of HDAC8 in FMD or pulmonary fibrosis has never been reported. This study investigated the role of HDAC8 in pulmonary fibrosis with a focus on FMD. We observed that HDAC8 expression was increased in IPF lung tissue as well as transforming growth factor (TGF)β1-treated normal human lung fibroblasts (NHLFs). Immunoprecipitation experiments revealed that HDAC8 was associated with α-SMA in TGFβ1-treated NHLFs. HDAC8 inhibition with NCC170 (HDAC8-selective inhibitor) repressed TGFβ1-induced fibroblast contraction and α-SMA protein expression in NHLFs cultured in collagen gels. HDAC8 inhibition with HDAC8 siRNA also repressed TGFβ1-induced expression of profibrotic molecules such as fibronectin and increased expression of antifibrotic molecules such as peroxisome proliferator-activated receptor-γ (PPARγ). Chromatin immunoprecipitation quantitative PCR using an antibody against H3K27ac (histone H3 acetylated at lysine 27; a known HDAC8 substrate and a marker for active enhancers) suggested that HDAC8 inhibition with NCC170 ameliorated TGFβ1-induced loss of H3K27ac at the PPARγ gene enhancer. Furthermore, NCC170 treatment significantly decreased fibrosis measured by Ashcroft score as well as expression of type 1 collagen and fibronectin in bleomycin-treated mouse lungs. These data suggest that HDAC8 contributes to pulmonary fibrosis and that there is a therapeutic potential for HDAC8 inhibitors to treat IPF as well as other fibrotic lung diseases.


Gene | 2017

Carcinogenic effects of oil dispersants: A KEGG pathway-based RNA-seq study of human airway epithelial cells.

Yao-Zhong Liu; Lei Zhang; Astrid M. Roy-Engel; Shigeki Saito; Joseph A. Lasky; Guangdi Wang

The health impacts of the BP oil spill are yet to be further revealed as the toxicological effects of oil products and dispersants on human respiratory system may be latent and complex, and hence difficult to study and follow up. Here we performed RNA-seq analyses of a system of human airway epithelial cells treated with the BP crude oil and/or dispersants Corexit 9500 and Corexit 9527 that were used to help break up the oil spill. Based on the RNA-seq data, we then systemically analyzed the transcriptomic perturbations of the cells at the KEGG pathway level using two pathway-based analysis tools, GAGE (generally applicable gene set enrichment) and GSNCA (Gene Sets Net Correlations Analysis). Our results suggested a pattern of change towards carcinogenesis for the treated cells marked by upregulation of ribosomal biosynthesis (hsa03008) (p=1.97E-13), protein processing (hsa04141) (p=4.09E-7), Wnt signaling (hsa04310) (p=6.76E-3), neurotrophin signaling (hsa04722) (p=7.73E-3) and insulin signaling (hsa04910) (p=1.16E-2) pathways under the dispersant Corexit 9527 treatment, as identified by GAGE analysis. Furthermore, through GSNCA analysis, we identified gene co-expression changes for several KEGG cancer pathways, including small cell lung cancer pathway (hsa05222, p=9.99E-5), under various treatments of oil/dispersant, especially the mixture of oil and Corexit 9527. Overall, our results suggested carcinogenic effects of dispersants (in particular Corexit 9527) and their mixtures with the BP crude oil, and provided further support for more stringent safety precautions and regulations for operations involving long-term respiratory exposure to oil and dispersants.


American Journal of Physiology-lung Cellular and Molecular Physiology | 2017

TGF-β1 stimulates HDAC4 nucleus-to-cytoplasm translocation and NADPH oxidase 4-derived reactive oxygen species in normal human lung fibroblasts

Weichao Guo; Shigeki Saito; Cecilia G. Sanchez; Yan Zhuang; Rafael E. Gongora Rosero; Bin Shan; Fayong Luo; Joseph A. Lasky

Myofibroblasts are important mediators of fibrogenesis; thus blocking fibroblast-to-myofibroblast differentiation (FMD) may be an effective strategy to treat pulmonary fibrosis (PF). Previously, we reported that histone deacetylase 4 (HDAC4) activity is necessary for transforming growth factor-β1 (TGF-β1)-induced human lung FMD. Here, we show that TGF-β1 increases NADPH oxidase 4 (NOX4) mRNA and protein expression in normal human lung fibroblasts (NHLFs) and causes nuclear export of HDAC4. Application of the NOX family inhibitor diphenyleneiodonium chloride reduces TGF-β1-induced HDAC4 nuclear export, expression of the myofibroblast marker α-smooth muscle actin (α-SMA), and α-SMA fiber formation. Inhibition of HDAC4 nucleus-to-cytoplasm translocation using leptomycin B (LMB) had little effect on α-SMA expression but blocked α-SMA fiber formation. A coimmunoprecipitation assay showed that HDAC4 associates with α-SMA. Moreover, LMB abolishes TGF-β1-induced α-SMA fiber formation and cell contraction. Relevant to human pulmonary fibrosis, idiopathic PF specimens showed significantly higher NOX4 RNA expression and scant HDAC4 staining within nuclei of fibroblast foci myofibroblasts. Taken together, these results indicate that reactive oxygen species promote TGF-β1-mediated myofibroblast differentiation and HDAC4 nuclear export. The physical association of HDAC4 with α-SMA suggests that HDAC4 has a role in regulating the α-SMA cytoskeleton arrangement.


Chest | 2011

Low-Dose Tissue Plasminogen Activator in Pulmonary Embolism: Benefit Remains Unclear

Shigeki Saito; Basal Altaqi; Francesco Simeone

Age, y 58.0 6 17.6 46.5 6 23.0 52.4 6 21.0 Length of stay, d 19 6 43 23 6 11 20.9 6 31 Admission unit Trauma 17 (34) 22 (44) 39 (39) General Surgery 14 (30) 10 (20) 24 (24) Medical 9 (18) 10 (20) 19 (19) Cardiovascular Surgery 9 (18) 8 (16) 17 (17) APACHE II score 18 6 9 20 6 6 19 6 8 Corticosteroids 15 (30) 18 (36) 33 (33) Antibiotic 45 (90) 47 (94) 92 (92) Duration, d 11.3 6 8.2 18.0 6 12.7 14.8 6 11.0 Mechanical ventilation 44 (88) 48 (96) 92 (92) Duration, d 10.4 6 8.8 19.2 6 12.3 15.1 6 12.0 Mortality 7 (14) 7 (14) 14 (14)


Chest | 2018

USE OF THE STOP-BANG QUESTIONNAIRE AS A SCREENING TOOL FOR OSA IN PATIENTS WITH OR AT RISK FOR PULMONARY HYPERTENSION

Michael Lanasa; Bennett P. deBoisblanc; Lesley Ann Saketkoo; Shigeki Saito; Monique Brown; Matthew R. Lammi


american thoracic society international conference | 2011

Transition From Intravenous Prostanoid Therapy To Inhaled Trepostinil In Patients With Severe Pulmonary Arterial Hypertension: A Preliminary Multicenter Experience

Vinicio de Jesus Perez; Erika B. Rosenzweig; Lewis J. Rubin; Abubakr Bajwa; Myung H. Park; Juliana Liu; Edda Spiekerkoetter; Shigeki Saito; Andrew Hsi; Roham T. Zamanian


american thoracic society international conference | 2010

A Role For Histone Deacetylase 6 (HDAC6) In Thrombin-Induced Endothelial Barrier Dysfunction

Shigeki Saito; Joseph A. Lasky; Bin Shan

Collaboration


Dive into the Shigeki Saito's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Abubakr Bajwa

University of Florida Health Science Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge